Posts by: David Melamed

News

Cure SMA, a nonprofit group supporting people with spinal muscular atrophy (SMA) and investing in SMA research, will host its first-ever virtual gala on Tuesday, Oct. 27, in an event ... Read more

October 7, 2020October 9, 2020

EU Approves EONIS System to Screen Newborns for SMA, Other Conditions

News

The EONIS system, a screening assay capable of simultaneously testing newborns for three genetic conditions, including spinal muscular atrophy (SMA), has received a CE marking from the European Commission for ... Read more

September 14, 2020September 14, 2020

AveXis Now Known as Novartis Gene Therapies, Focus of Continuing Work

News

Two years after acquiring the gene therapy company AveXis, Novartis has renamed it Novartis Gene Therapies to underscore the potential value of developing such treatments for genetic diseases. This decision ... Read more

August 5, 2020August 5, 2020

Cure SMA Offers Free Medical Alert Bracelet Kits to US Patients

News

Cure SMA has launched a new program to offer medical alert bracelets to spinal muscular atrophy (SMA) patients in the United States at no cost to the patient, according to ... Read more